Vol. 19 No. 1 (2019): June 2019

Published: 2019-06-27

Editorials

Diabetes medications with cardiovascular protection after HARMONY Outcomes and DECLARE-TIMI 58: could metformin, pioglitazone, SGLT2 inhibitors and long-acting GLP-1 receptor agonists complement each other to save lives by different mechanisms?

Bob Ryder, Ralph DeFronzo

1-5
- PDF
- HTML
Taking confidence from CREDENCE and navigating with SONAR: new evidence for reducing renal failure in diabetes

Peter H Winocour

6-7
- PDF
- HTML

Original Research

Prevalence of co-morbidities in a specialist weight management programme prior to bariatric surgery

Daniel Fountain, Mohammed Al Kharaiji, Sherif Awad, David Hughes, Iskandar Idris

8-13
- PDF
- HTML
A comparison of follow-up rates of women with gestational diabetes before and after the updated National Institute for Health and Care Excellence guidance advocating routine follow-up, and the association with neighbourhood deprivation

Sebastian Walsh, Mahmoud Mahmoud, Htwe Htun, Sheena Hodgett, David Barton

14-18
- PDF
- HTML
Does the use of a colour coded inpatient capillary blood glucose monitoring chart influence outcomes?

Dhiraj Sharma, Matthew Gerlach, Vivek Sharma, Ketan Dhatariya

19-24
- PDF
- HTML
NICE targeted screening to identify gestational diabetes: who are we missing?

Canel Kucuk, Ali J Chakera, Elaine Macaninch

25-28
- PDF
- HTML
A survey of the management of 16–18-year-olds presenting with diabetic ketoacidosis in the UK: a need for standardisation

Ketan Dhatariya, Peter Winocour, Andrew Raffles

29-33
- PDF
- HTML

Current Topics

Series: Cardiovascular outcome trials for diabetes drugs Saxagliptin and SAVOR-TIMI 53

Miles Fisher

34-36
- PDF
- HTML
SGLT inhibitors and euglycaemic diabetic ketoacidosis: earlier observations rediscovered

Salem A Beshyah, Brian M Frier

37-41
- PDF
- HTML

Learning from practice

A Health Equity Audit of the Diabetic Eye Screening Programmes in Cumbria and the North East

Balsam Ahmad, Fergus Neilson

42-44
- PDF
- HTML
Low rates of hyponatraemia in patients with diabetes treated with variable rate intravenous insulin infusion (VRIII)

Zeenat Banu, Daniel Flanagan

45-48
- PDF
- HTML
Changing inpatient diabetes care in a district general hospital

Marie Wallner, Basharat Andrabi, David Russell-Jones, Roselle Herring

49-52
- PDF
- HTML
ENHIDE telehealth primary care support of adults with diabetes and chronic kidney disease: a pilot study – rationale and study design

Peter H Winocour, Karen Moore-Haines, Andrew Solomon, Anne Currie, Dawn Hardy

53-62
- PDF
- HTML

Case Reports

Recurrent spondylodiscitis secondary to hallux osteomyelitis

Aleksandra Staniszewska, Elizabeth Ballingall, Peter Schnatterbeck, Christopher R Lattimer, Amit Amin, William Lynn, Sanjeev Mehta

63-65
- PDF
- HTML

Position Statements

Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019)

Umesh Dashora, Dipesh C Patel, Robert Gregory, Peter Winocour, Ketan Dhatariya, Dinesh Nagi

66-72
- PDF
- HTML
Remission of type 2 diabetes: a position statement from the Association of British Clinical Diabetologists (ABCD) and the Primary Care Diabetes Society (PCDS)

Dinesh Nagi, Clare Hambling, Roy Taylor

73-76
- PDF
- HTML

Meeting Reports

Joint ABCD-RA Meeting

Ana Pokrajac

77
- PDF
- HTML

Abstracts

ABCD Renal Association Abstracts 2019

Admin Two

78-79
- PDF
- HTML
ABCD Autumn Meeting Abstracts 2018

Admin Two

79
- PDF
- HTML

ABCD News

ABCD and YDEF News

Dinesh Nagi, Umesh Dashora, Rebecca Reeve, Tim Robbins

81-92
- PDF
- HTML